MiMedx Group, Inc. (NASDAQ:MDXG)

CAPS Rating: 2 out of 5

MDXG News and Commentary

Caps

How do you think MDXG will perform against the market?

Add Stock to CAPS Watchlist

All Players

47 Outperform
12 Underperform
 

All-Star Players

15 Outperform
7 Underperform
 

Wall Street

2 Outperform
0 Underperform
 

Top MDXG Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFPencils (99.92)
Submitted January 24, 2018

Not a company I've followed closely up to this point, but gotta say there is a lot to like. Revenue is growing quickly, and that growth is increasingly benefiting the bottom line and overall free cash flow production. Clean balance sheet with no… More

oldwickdave (< 20)
Submitted February 10, 2017

Shorts have continued to overplay this and remains undervalued .

MDXG VS S&P 500 (SPY)

Fools bullish on MDXG are also bullish on:

Fools bearish on MDXG are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about MDXG.

Recs

0
Member Avatar ifpt999 (60.05) Submitted: 6/20/2018 10:58:57 AM : Outperform Start Price: $5.55 MDXG Score: +8.14

At this point MDXG will probably be delisted as they must restate years of SEC filings due to improper accounting of related party transactions.

However, their products are good, patients and doctors love them. They are the best at what they do addressing a need that has few substitutes. I suspect this is a three bagger in 2-3 years.

Recs

2
Member Avatar TMFPencils (99.92) Submitted: 1/24/2018 12:41:04 PM : Outperform Start Price: $14.64 MDXG Score: -56.42

Not a company I've followed closely up to this point, but gotta say there is a lot to like. Revenue is growing quickly, and that growth is increasingly benefiting the bottom line and overall free cash flow production. Clean balance sheet with no debt. Aiming to generate $560 million in revenue by 2020 (nearly doubling today's revenue).

Management sees a market opportunity in the tens of billions, and is aiming to hit $1 billion of revenue by 2023. Seems like a business that can continue growing at above-average rates for a long time -- although the risk is that I don't have a grasp on the placental market (surprising, I know).

This is high on my list of companies I want to follow closely and learn about. In the meantime, I like what I see. Outperform.

Recs

0
Member Avatar TMFTypeoh (92.64) Submitted: 10/23/2017 3:43:53 PM : Outperform Start Price: $12.28 MDXG Score: -58.53

MDGX - company is growing fast and defending itself against short-sellers claims. Recently authorized $10 million stock repurchase plan after exhausting a $100 million one. One of the fortunes fastest growing businesses. I like the odds of outperformance from here.

Leaderboard

Find the members with the highest scoring picks in MDXG.

Score Leader

portefeuille6

portefeuille6 (99.57) Score: +81.02

The Score Leader is the player with the highest score across all their picks in MDXG.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
vj507 38.81 2/10/2015 Underperform 5Y $8.24 -27.43% +33.57% +60.99 0 Comment
oldwickdave < 20 2/10/2017 Underperform 3M $8.17 -26.81% +18.94% +45.74 1 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. chammond55 94.42 2/20/2018 Underperform 5Y $9.05 -33.92% +0.82% +34.74 0 Comment
soonerbear98 < 20 10/3/2013 Underperform 5Y $4.52 +32.30% +62.77% +30.47 0 Comment
walhersh 97.34 5/29/2018 Underperform 1Y $8.40 -28.78% +1.34% +30.12 0 Comment
sn0wf0g < 20 5/29/2018 Underperform 1Y $8.29 -27.86% +2.21% +30.07 0 Comment
BigCaps18 < 20 3/26/2018 Underperform 5Y $6.90 -13.33% +4.81% +18.14 0 Comment
PAGEBOY73 98.44 5/16/2018 Underperform NS $7.19 -16.82% +0.81% +17.63 0 Comment
Carvski 87.79 5/17/2018 Underperform 5Y $7.15 -16.36% +0.87% +17.23 0 Comment
srkenne264 99.15 4/9/2018 Underperform 5Y $6.53 -8.42% +5.12% +13.54 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 85.44 10/20/2015 Outperform 3W $8.89 -32.73% +35.28% -68.01 0 Comment
TrackJimCramer 85.44 8/10/2015 Underperform 3W $9.37 -5.12% -3.58% +1.54 10/20/2015 @ $8.89 0 Comment
TrackJimCramer 85.44 5/29/2015 Outperform 3W $10.35 -9.47% -0.24% -9.23 8/10/2015 @ $9.37 0 Comment
TrackCanaccord 71.67 12/20/2013 Outperform NS $7.77 -23.04% +52.07% -75.10 0 Comment

Featured Broker Partners


Advertisement